Adverse event reporting
This article was originally published in The Tan Sheet
Executive Summary
FDA publishes in the Jan. 27 Federal Register a proposed regulation pre-empting state or local laws that allow disclosure to patients or reporters of adverse events associated with FDA- regulated products. Commissioner David Kessler announced the upcoming regs Jan. 21 ("The Tan Sheet" Jan. 24. p. 3)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning